BSE filing, NSE: MASTERTR. Summary written from the filing by ALFA Finder's alert engine.
Master Trust Ltd: key numbers
- Share price
- ₹80.10
- Market cap
- ₹985.4 Cr
- Revenue (annual)
- ₹575.8 Cr
- Net profit (annual)
- ₹126.0 Cr
- P/E (TTM)
- 7.0×Sector 19.5×
- Promoter holding
- 71.93%+0.00% QoQ
- FII holding
- 0.31%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Master Trust Ltd
All →Master Trust Investor Presentation: Key Takeaways
Q2 FY27 total income ₹1,537Mn (+21.1% YoY), PAT ₹383Mn (+21.9% YoY); H1 PAT ₹729Mn (+24.7%). Strategy: diversify beyond broking.
Master Trust Q2 FY27 Results: Net Profit ₹38.3 Cr, Up 22.0% YoY
Master Trust Ltd reported revenue from operations of ₹153.7 Cr (+21.1% YoY) and net profit of ₹38.3 Cr (+22.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹38.3 Cr · +22.0% YoY
Master Trust Board Meeting Date
Master Trust Ltd intimated its Board meeting scheduled for 03 Nov 2026 to approve Q1/H1 un-audited financial results. No financial figures are disclosed in this advance notice.
Master Trust Business Update
Master Trust Limited’s subsidiary, Master Capital Services Limited, has commenced clearing and settlement services for F&O trades on NSE and BSE, effective October 15, 2026.
Master Trust Capacity Expansion
Master Capital Services Ltd, a wholly owned subsidiary of Master Trust Ltd, commenced F&O clearing and settlement services on NSE and BSE effective 15 October 2026. No monetary value is disclosed.
Master Trust Other Announcement
Master Trust Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Other results update announcements
All →Muthoot Microfin Results Update
Muthoot Microfin reported Q2 FY27 PAT of Rs. 110.8 crore, up 262.9% YoY, alongside a record Rs. 2,900 crore in disbursements. CareEdge revised its outlook to Positive.
Glenmark Pharmaceuticals Results Update
Glenmark Pharmaceuticals released its Q2 FY27 press release and MD&A for the quarter ended September 2026. Highlights show India growth and lower North America revenue.
Hindalco Industries Results Update
Hindalco filed Novelis's Q2 FY27 news release and earnings presentation, released on the subsidiary's website. The release highlights net sales up 25% year-on-year.
Ivalue Infosolutions Results Update
iValue Infosolutions released a press release on its unaudited Q2FY27 and half-year results ended 30 September 2026. The release highlights revenue, EBITDA and PAT growth quarter-on-quarter.
Indian Hume Pipe Company Results Update
Indian Hume Pipe's Q2 FY27 net profit fell to Rs.22.75 crore from Rs.34.69 crore, with revenue from operations down 21%. Half-year revenue from operations fell 12% year-on-year.
Protean eGov Technologies Results Update
Protean eGov reported Q2FY27 revenue of INR 271 crore, up 8% YoY, and PAT of INR 16 crore. The company stated it holds zero debt.